These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 21666206)

  • 21. Measles and rubella in the World Health Organization European region: diversity creates challenges.
    Spika JS; Wassilak S; Pebody R; Lipskaya G; Deshevoi S; Guris D; Emiroglu N
    J Infect Dis; 2003 May; 187 Suppl 1():S191-7. PubMed ID: 12721913
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Measles elimination programme on the world and Poland].
    Makówka A; Gut W; Litwińska B
    Przegl Epidemiol; 2007; 61(1):135-42. PubMed ID: 17702452
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Can a minimum rate of investigation of measleslike illnesses serve as a standard for evaluating measles surveillance?
    Harpaz R; Papania MJ
    J Infect Dis; 2004 May; 189 Suppl 1():S204-9. PubMed ID: 15106112
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Measles at the point of being eliminated].
    De Ory F; Peña-Rey I
    Enferm Infecc Microbiol Clin; 2010 Feb; 28(2):73-4. PubMed ID: 20096973
    [No Abstract]   [Full Text] [Related]  

  • 25. [Evaluation of clinical laboratories--assurance of their quality and competence].
    Kawai T
    Rinsho Byori; 2007 Jan; 55(1):59-62. PubMed ID: 17319492
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Measles and rubella laboratory network: 2007 meeting on use of alternative sampling techniques for surveillance.
    Wkly Epidemiol Rec; 2008 Jun; 83(25):229-32. PubMed ID: 18572479
    [No Abstract]   [Full Text] [Related]  

  • 27. [History of ISO 15189 and its future perspective].
    Kawai T
    Rinsho Byori; 2010 Jan; 58(1):64-8. PubMed ID: 20169946
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Procedure for accurate evaluation of laboratory data and its international trends].
    Kuwa K
    Rinsho Byori; 2005 Jun; 53(6):531-9. PubMed ID: 16026081
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Challenges of measles and rubella laboratory diagnostic in the era of elimination.
    Hübschen JM; Bork SM; Brown KE; Mankertz A; Santibanez S; Ben Mamou M; Mulders MN; Muller CP
    Clin Microbiol Infect; 2017 Aug; 23(8):511-515. PubMed ID: 28412379
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The running status of Chinese Measles Laboratory Network in 2008].
    Zhang Y; Xu ST; Jiang XH
    Zhongguo Yi Miao He Mian Yi; 2009 Apr; 15(2):104-7. PubMed ID: 20077651
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Global measles elimination efforts: the significance of measles elimination in the United States.
    Strebel PM; Henao-Restrepo AM; Hoekstra E; Olive JM; Papania MJ; Cochi SL
    J Infect Dis; 2004 May; 189 Suppl 1():S251-7. PubMed ID: 15106119
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The rapid diagnosis of rubella and measles by the dot immunoassay method].
    Arroyave CM
    Bol Med Hosp Infant Mex; 1993 Jun; 50(6):399-405. PubMed ID: 8517935
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of the virology diagnosis laboratory in the surveillance of rubella virus Cuba 1988/2000.
    de Los Angeles Ribas M; Galindo M; Torres G; Valcarsel M; Cancio R; Guzmán MG; Rosario D; Resik S; Rodriguez C; Garcia D; Tejero Y
    Vaccine; 2004 Oct; 22(31-32):4287-90. PubMed ID: 15474720
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Field experience in implementing ISO 15189 in Kisumu, Kenya.
    Zeh CE; Inzaule SC; Magero VO; Thomas TK; Laserson KF; Hart CE; Nkengasong JN;
    Am J Clin Pathol; 2010 Sep; 134(3):410-8. PubMed ID: 20716797
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The World Health Organization/International Union Against Tuberculosis and Lung Disease Global Project on Surveillance for Anti-Tuberculosis Drug Resistance: a model for other infectious diseases.
    Aziz MA; Wright A
    Clin Infect Dis; 2005 Aug; 41 Suppl 4():S258-62. PubMed ID: 16032561
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Progress toward elimination of measles and prevention of congenital rubella infection--European region, 1990-2004.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2005 Feb; 54(7):175-8. PubMed ID: 15729220
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Status of rubella and congenital rubella syndrome surveillance, 2005-2009, the World Health Organization European Region.
    Zimmerman LA; Muscat M; Jankovic D; Goel A; Bang H; Khetsuriani N; Martin R
    J Infect Dis; 2011 Jul; 204 Suppl 1():S381-8. PubMed ID: 21666188
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Microbiological Surveillance of Measles and Rubella in Spain. Laboratory Network].
    Echevarría JE; Fernández García A; de Ory F
    Rev Esp Salud Publica; 2015; 89(4):381-91. PubMed ID: 26580793
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Progress in measles and rubella elimination in Iran.
    Esteghamati A; Gouya MM; Zahraei SM; Dadras MN; Rashidi A; Mahoney F
    Pediatr Infect Dis J; 2007 Dec; 26(12):1137-41. PubMed ID: 18043452
    [TBL] [Abstract][Full Text] [Related]  

  • 40. What will it take to achieve measles elimination in the World Health Organization European Region: progress from 2003-2009 and essential accelerated actions.
    Martin R; Wassilak S; Emiroglu N; Uzicanin A; Deshesvoi S; Jankovic D; Goel A; Khetsuriani N
    J Infect Dis; 2011 Jul; 204 Suppl 1(Suppl 1):S325-34. PubMed ID: 21666181
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.